Kala Pharmaceuticals - Stock Price History | KALA

Historical daily share price chart and data for Kala Pharmaceuticals since 2021 adjusted for splits. The latest closing stock price for Kala Pharmaceuticals as of October 27, 2021 is 1.75.
  • The all-time high Kala Pharmaceuticals stock closing price was 26.53 on September 14, 2017.
  • The Kala Pharmaceuticals 52-week high stock price is 9.97, which is 469.7% above the current share price.
  • The Kala Pharmaceuticals 52-week low stock price is 1.75, which is 0% below the current share price.
  • The average Kala Pharmaceuticals stock price for the last 52 weeks is 5.82.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Kala Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 8.6256 3.8400 13.7900 3.8300 6.7800 83.74%
2019 5.5994 5.1900 8.9700 3.3600 3.6900 -24.54%
2018 12.4166 18.9800 18.9800 4.2900 4.8900 -73.55%
2017 20.1858 18.4900 26.5300 13.6800 18.4900 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.117B $0.006B
Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles technology. The Company designs proprietary drug delivery technology to penetrate mucosal tissue such as the eyes, lungs, gastrointestinal tracts and the female reproductive systems. Kala Pharmaceuticals, Inc. is based in Waltham, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86